Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.150 | None | 1.000 | 749 | 705 | 1975 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.130 | None | 1.000 | 704 | 1021 | 1996 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.700 | definitive | 1.000 | 465 | 2258 | 1976 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.400 | None | 1.000 | 437 | 20 | 1989 | 2020 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 415 | 9 | 2003 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.700 | definitive | 1.000 | 407 | 2632 | 1988 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 406 | 9 | 2003 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.170 | None | 1.000 | 367 | 203 | 1989 | 2018 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.700 | None | 1.000 | 352 | 7 | 1997 | 2020 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
phenotype | 0.400 | None | 1.000 | 342 | 5 | 1997 | 2020 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.600 | None | 1.000 | 338 | 5 | 1997 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.130 | None | 1.000 | 323 | 309 | 1990 | 2018 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.150 | None | 1.000 | 303 | 189 | 1978 | 2018 | ||||||||
|
gap junction protein beta 2 | 0.441 | 0.846 | 6.6E-16 |
|
disease | 0.900 | None | 1.000 | 260 | 95 | 1997 | 2019 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 259 | 0 | 2010 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.700 | None | 1.000 | 254 | 221 | 1976 | 2018 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.900 | definitive | 1.000 | 244 | 223 | 1991 | 2018 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.600 | None | 1.000 | 242 | 4 | 1990 | 2019 | ||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
disease | 1.000 | definitive | 1.000 | 234 | 139 | 1996 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.100 | None | 1.000 | 233 | 561 | 1989 | 2018 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
group | 0.100 | None | 1.000 | 231 | 0 | 1994 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 218 | 2 | 2002 | 2020 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
group | 0.700 | None | 1.000 | 216 | 10 | 1983 | 2019 | ||||||||
|
myosin heavy chain 7 | 0.516 | 0.692 | 4.2E-16 |
|
disease | 0.700 | strong | 1.000 | 216 | 145 | 1961 | 2017 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 213 | 0 | 2000 | 2020 |